- Comp & Benefits
- Work/Life Balance
- Senior Management
- Culture & Values
- Career Opportunities
I have been working at ImClone as an intern (less than an year)Pros
Wonderful staff, always something new to learn, and opportunities to move up. I really enjoyed working with this company and would do it again.Cons
After being bought by Lilly, the community aspect lessened. Morale also decreased. However, this is only known if you worked there before the takeover. The company is still great after acquisition just not as awesome as it used to be.RecommendsPositive OutlookNo opinion of CEO
Getting an Interview
Getting an Interview
- Application Details
I applied through a recruiter. The process took 4 weeks – interviewed at ImClone in November 2010.Interview Details
1. Contacted by recruiter. Job description was detailed with role and responsibilities clearly defined.
2. Updated my resume to highlight required skills. Recruiter submitted application and sent me
a login ID and password on ImClone website
3. Completed profile on the ImClone website.
4. Phone interview with hiring manager. Interview went well. Got the impression that ImClone was
still working on integration issues related to 2008 merge with Eli Lilly and that the responsibilities
of the position was fluid.
5. Face to face interviews with senior leadership. First two interviews went fairly well. Again the nature of
the interview was not specific to the job description, more like an evaluation of where my experience
and skills would best fit in. The final interview focused on in-depth understanding of research, one
of ImClone's core businesses and something which was not my strength and also not a critical
requirement for the PMO role I was being interviewed for.
For senior positions, it is probably necessary to be knowledgeable about all the core business of the company one is being interviewed at regardless of the specific role being filled.Interview Questions
No OfferNegative ExperienceAverage Interview
- In three sentences or less, how would you define a database to a 3 year old ? View Answer
Let us know if we're missing any workplace or industry recognition –
ImClone Systems wants to create identically successful cancer drug candidates. The company, a subsidiary of Eli Lilly, is focused on the development of oncology-related antibody therapies. The biotech research firm's only commercial product, Erbitux, is approved for treatment of colorectal cancer, as well as head and neck cancers. ImClone Systems co-promotes the drug with Bristol-Myers Squibb (BMS) in North America and with Merck KGaA elsewhere. The company is continuing to develop Erbitux as a possible treatment for other kinds of cancer, including lung cancer. It also...